voices from american medicine

Healthcare reform has become a leading debate in the media, with supporters of single payer systems touting projections of quality improvements and cost savings alongside other benefits. But what are some of the drawbacks of a one-size-fits-all? That’s the question psychiatrist Dr. Asim Shah addressed in a recent op-ed article from the Houston Chronicle he co-authored.

Healthcare reform has become a leading debate in the media, with supporters of single payer systems touting projections of quality improvements and cost savings alongside other benefits. But what are some of the drawbacks of a one-size-fits-all? That’s the question psychiatrist Dr. Asim Shah addressed in a recent op-ed article from the Houston Chronicle he co-authored.

Healthcare reform has become a leading debate in the media, with supporters of single payer systems touting projections of quality improvements and cost savings alongside other benefits. But what are some of the drawbacks of a one-size-fits-all? That’s the question psychiatrist Dr. Asim Shah addressed in a recent op-ed article from the Houston Chronicle he co-authored.

Terms like single-payer, universal coverage, and Medicare for All often land at the center of political discussions andat times, get used interchangeably. But as Dr. Jodi Liu, Professor and Associate Policy Researcher at the Pardee RAND Graduate School, explains, these terms can carry different meanings, expectations, and projected impacts on healthcare systems.

Terms like single-payer, universal coverage, and Medicare for All often land at the center of political discussions andat times, get used interchangeably. But as Dr. Jodi Liu, Professor and Associate Policy Researcher at the Pardee RAND Graduate School, explains, these terms can carry different meanings, expectations, and projected impacts on healthcare systems.

The subject of single-payer healthcare is at the forefront of practically every political discussion and debate. Providing unique perspectives on its strengths and setbacks is nationally-renowned advocate Dr. David Himmelstein.

The subject of single-payer healthcare is at the forefront of practically every political discussion and debate. Providing unique perspectives on its strengths and setbacks is nationally-renowned advocate Dr. David Himmelstein.

How do we define single-payer healthcare at the national and state levels, respectively, and is either model even realistic for large scale implementation? Dr. Maichael Sparer, Professor and Chair in the Department of Health Policy and Management at the Mailman School of Public Health, joins Mario Nacinovich to shed light on this topic.

How do we define single-payer healthcare at the national and state levels, respectively, and is either model even realistic for large scale implementation? Dr. Maichael Sparer, Professor and Chair in the Department of Health Policy and Management at the Mailman School of Public Health, joins Mario Nacinovich to shed light on this topic.

How has public opinion on the idea of a national single-payer healthcare model changed since the late 1990s? Liz Hamel, Vice President and Director of Public Opinion and Survey Research at the Kaiser Family Foundation is here to answer that exact question, as well as reveal the factors, like political party identification and word choice, that affect outlooks toward this type of healthcare model.

How has public opinion on the idea of a national single-payer healthcare model changed since the late 1990s? Liz Hamel, Vice President and Director of Public Opinion and Survey Research at the Kaiser Family Foundation is here to answer that exact question, as well as reveal the factors, like political party identification and word choice, that affect outlooks toward this type of healthcare model.

In today’s polarized political climate, the road toward greater healthcare access, delivery, and cost coverage is still highly uncertain. So to help shed light on some of the merits and challenges of a single-payer model, Dr. Matt Birnholz sits down with Dr. Kenneth Thorpe, the Robert W. Woodruff Professor and Chair of the Department of Health Policy and Management in the Rollins School of Public Health of Emory University.

In today’s polarized political climate, the road toward greater healthcare access, delivery, and cost coverage is still highly uncertain. So to help shed light on some of the merits and challenges of a single-payer model, Dr. Matt Birnholz sits down with Dr. Kenneth Thorpe, the Robert W. Woodruff Professor and Chair of the Department of Health Policy and Management in the Rollins School of Public Health of Emory University.

On this episode of Voices From American Medicine, Dr. Matt Birnholz speaks with James Capretta, a Resident Fellow at the American Enterprise Institute, studying health care, entitlement, and US budgetary policy, as well as global trends in aging, health, and retirement programs. They discuss the future for American health care policy, and where health care professionals and the general public alike will go from here.

On this episode of Voices From American Medicine, Dr. Matt Birnholz speaks with James Capretta, a Resident Fellow at the American Enterprise Institute, studying health care, entitlement, and US budgetary policy, as well as global trends in aging, health, and retirement programs. They discuss the future for American health care policy, and where health care professionals and the general public alike will go from here.

On this episode of Voices From American Medicine, Dr. Matt Birnholz speaks with James Capretta, a Resident Fellow at the American Enterprise Institute, studying health care, entitlement, and US budgetary policy, as well as global trends in aging, health, and retirement programs. They discuss the future for American health care policy, and where health care professionals and the general public alike will go from here.

The Affordable Care Act was passed in 2010 to provide more Americans access to affordable quality health insurance and to reduce health care spending. But have these goals actually been met, and if not, what will it take to get there?

On this episode of Voices From American Medicine, Dr. Matt Birnholz speaks with James Capretta, a Resident Fellow at the American Enterprise Institute, studying health care, entitlement, and US budgetary policy, as well as global trends in aging, health, and retirement programs. Mr. Capretta has directed several major studies, including one on reforming US healthcare according to market principles and consumer choice.

The Affordable Care Act was passed in 2010 to provide more Americans access to affordable quality health insurance and to reduce health care spending. But have these goals actually been met, and if not, what will it take to get there?

On this episode of Voices From American Medicine, Dr. Matt Birnholz speaks with James Capretta, a Resident Fellow at the American Enterprise Institute, studying health care, entitlement, and US budgetary policy, as well as global trends in aging, health, and retirement programs. Mr. Capretta has directed several major studies, including one on reforming US healthcare according to market principles and consumer choice.

The Affordable Care Act was passed in 2010 to provide more Americans access to affordable quality health insurance and to reduce health care spending. But have these goals actually been met, and if not, what will it take to get there?

On this episode of Voices From American Medicine, Dr. Matt Birnholz speaks with James Capretta, a Resident Fellow at the American Enterprise Institute, studying health care, entitlement, and US budgetary policy, as well as global trends in aging, health, and retirement programs. Mr. Capretta has directed several major studies, including one on reforming US healthcare according to market principles and consumer choice.

Interest in health policies related to drug pricing has spiked in recent times. While remarkable research discoveries have positively escalated the pharmaceutical industry with release of more novel drugs, the question on how drugs should be priced is continually resurfacing. How are high drug costs justified when they become financially inaccessible to many patients, and what measures are being put in place to address these access gaps?

Host Frank Russomano welcomes Andrew Rosenberg J.D. of the CME Coalition and Thomas Sullivan, President of Rockpointe Corporation and editor of Policy and Medicine, to discuss recent developments in drug pricing.